doi:10.3969/j.issn.1004-583X.2022.06.016

Abstract

CLC Number:

R573.9

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.06.016

https://huicui.hebmu.edu.cn/EN/Y2022/V37/I6/560

References 34

[1]	中国医疗保健国际交流促进会胃食管反流多学科分会. 中国胃食管反流病多学科诊疗共识[J]. 中国医学前沿杂志:电子版, 2019, 11(9):30-56.
[2]	Guo Z, Wu Y, Chen J, et al. The role of salivary pepsin in the diagnosis of gastroesophageal reflux disease (GERD) evaluated using high-resolution manometry and 24-hour multichannel intraluminal impedance-ph monitoring[J]. Med Sci Monit, 2020, 26: e927381.
[3]	邹亚竹. 胃蛋白酶与反流相关性疾病研究进展[J]. 检验医学与临床, 2018, 15(22):3472-3475.
[4]	Klimara M, Johnston N, Samuels T, et al. Correlation of salivary and nasal lavage pepsin with MII-pH testing[J]. Laryngoscope, 2020, 130(4): 961-966. doi: 10.1002/lary.28182
[5]	Wang J, Zhao Y, Ren J, et al. Pepsin in saliva as a diagnostic biomarker in laryngopharyngeal reflux: a meta-analysis[J]. Eur Arch Otorhinolaryngol, 2018, 275(3):671-678. doi: 10.1007/s00405-017-4845-8 URL
[6]	Akbulut S, Aydinli FE, Kuscu O, et al. Reliability and validity of the turkish reflux symptom index[J]. J Voice, 2020, 34(6): 965 e23-965 e28.
[7]	Vance D, Alnouri G, Shah P, et al. The validity and reliability of the reflux finding score[J]. J Voice, 2020 :S0892- 1997(20)30421-5.
[8]	Wang Y, Lang X, Wu D, et al. Salivary pepsin as an intrinsic marker for diagnosis of sub-types of gastroesophageal reflux disease and gastroesophageal reflux disease-related disorders[J]. J Neurogastroenterol Motil, 2020, 26(1): 74-84. doi: 10.5056/jnm19032 URL
[9]	Strugala V, Woodcock AD, Dettmar PW, et al. Detection of pepsin in sputum: a rapid and objective measure of airways reflux[J]. Eur Respir J, 2016, 47(1): 339-341. doi: 10.1183/13993003.00827-2015 pmid: 26541528
[10]	Wang C, Wang C, Lien H, et al. Saliva pepsin detection and proton pump inhibitor response in suspected laryngopharyngeal reflux[J]. Laryngoscope, 2019, 129(3): 709-714. doi: 10.1002/lary.27502 URL
[11]	Du X, Wang F, Hu Z, et al. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China[J]. BMC Gastroenterol, 2017, 17(1): 107. doi: 10.1186/s12876-017-0667-9 URL
[12]	Hayat J, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease[J]. Gut, 2015, 64(3): 373-80. doi: 10.1136/gutjnl-2014-307049 URL
[13]	郎秀琼, 何雨芩, 杨均, 等. 唾液胃蛋白酶在不同亚型胃食管反流病中的诊断价值[J]. 中华消化杂志, 2017, 37(7):473-475.
[14]	Kim T, Lee K, Yeo M, et al. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms[J]. Digestion, 2008, 77(3-4):201-206.
[15]	Weitzendorfer M, Antoniou S, Schredl P, et al. Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux[J]. Laryngoscope, 2020, 130(7): 1780-1786. doi: 10.1002/lary.28320
[16]	Na S, Kwon O, Lee Y, et al. Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux[J]. Laryngoscope, 2016, 126(12): 2770-2773. doi: 10.1002/lary.26018 URL
[17]	刘泽阳, 许洪波, 郭伟, 等. 胃蛋白酶在咽喉反流与喉癌中的临床意义及研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(7):559-562.
[18]	Zhang M, Chia C, Stanley C, et al. Diagnostic utility of salivary pepsin as compared with 24-hour dual ph/impedance probe in laryngopharyngeal reflux[J]. Otolaryngol Head Neck Surg, 2021, 164(2):375-380. doi: 10.1177/0194599820951183 URL
[19]	Barona-Lleo L, Barona-De Guzman R, Krstulovic C. The Diagnostic Usefullness of the Salivary Pepsin Test in Symptomatic Laryngopharyngeal Reflux[J]. J Voice, 2019, 33(6): 923-928. doi: S0892-1997(18)30081-X pmid: 30314932
[20]	Lechien J, Bobin F, Dapri G, et al. Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux Patients[J]. Laryngoscope, 2021, 131(2): 268-276. doi: 10.1002/lary.28736 URL
[21]	Yin C, Zhang S, Zhong J, et al. Pepsin and Laryngeal and Hypopharyngeal Carcinomas[J]. Clin Exp Otorhinolaryngol, 2021, 14(2): 159-168. doi: 10.21053/ceo.2020.00465 URL
[22]	Vaezi M, Sifrim D. Assessing old and new diagnostic tests for gastroesophageal reflux disease[J]. Gastroenterology, 2018, 154(2): 289-301. doi: 10.1053/j.gastro.2017.07.040 URL
[23]	Dy F, Amirault J, Mitchell P, et al. Salivary pepsin lacks sensitivity as a diagnostic tool to evaluate extraesophageal reflux disease[J]. J Pediatr, 2016, 177: 53-58. doi: 10.1016/j.jpeds.2016.06.033 URL
[24]	Zeleník K, Hránková V, Vrtková A, et al. Diagnostic value of the peptest in detecting laryngopharyngeal reflux[J]. J Clin Med, 2021, 10(13):2996. doi: 10.3390/jcm10132996 URL
[25]	Guo Z, Jiang J, Wu H, et al. Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis[J]. Medicine (Baltimore), 2021, 100(32): e26756. doi: 10.1097/MD.0000000000026756 URL
[26]	Lechien J, Bobin F, Muls V, et al. Saliva pepsin concentration of laryngopharyngeal reflux patients is influenced by meals consumed before the samples[J]. Laryngoscope, 2021, 131(2): 350-359. doi: 10.1002/lary.28756 URL
[27]	Jung A, Kwon O, Park J, et al. Association between pepsin in the saliva and the subjective symptoms in patients with laryngopharyngeal reflux[J]. J Voice, 2019, 33(2): 150-154. doi: S0892-1997(17)30298-9 pmid: 29174850
[28]	Lechien J, Bobin F, Muls V, et al. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring[J]. Eur Arch Otorhinolaryngol, 2020, 277(2): 511-520. doi: 10.1007/s00405-019-05711-2 pmid: 31679054
[29]	Bobin F, Journe F, Lechien J. Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes[J]. Laryngoscope, 2020, 130(5): 1278-1281. doi: 10.1002/lary.28260
[30]	Race C, Chowdry J, Russell J, et al. Studies of salivary pepsin in patients with gastro-oesophageal reflux disease[J]. Aliment Pharmacol Ther, 2019, 49(9): 1173-1180. doi: 10.1111/apt.15138 URL
[31]	Katzka D, Pandolfino J, Kahrilas P. Phenotypes of gastroesophageal reflux disease: Where rome, lyon, and montreal meet[J]. Clin Gastroenterol Hepatol, 2020, 18(4): 767-776. doi: 10.1016/j.cgh.2019.07.015 URL
[32]	Woodland P, Singendonk M, Ooi J, et al. Measurement of salivary pepsin to detect gastroesophageal reflux disease is not ready for clinical application[J]. Clin Gastroenterol Hepatol, 2019, 17(3): 563-565. doi: 10.1016/j.cgh.2018.05.016 URL
[33]	Fortunato J, D'agostino R, Lively M. Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients[J]. Neurogastroenterol Motil, 2017, 29(2).
[34]	Yadlapati R, Adkins C, Jaiyeola D, et al. Abilities of oropharyngeal pH tests and salivary pepsin analysis to discriminate between asymptomatic volunteers and subjects with symptoms of laryngeal irritation[J]. Clin Gastroenterol Hepatol, 2016, 14(4): 535-542.e2. doi: 10.1016/j.cgh.2015.11.017 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 34

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2014, 29(9): 1052-1054.
[2]	YUE Ya-guang;JIANG Kui;WANG Bang-mao. Efficacy of furazolidone and levofloxacin-containing quadruple therapy for eradication of Helicobacter pylori [J]. CLINICAL FOCUS, 2013, 28(7): 746-748.
[3]	. [J]. CLINICAL FOCUS, 2013, 28(3): 360-0.
[4]	. [J]. Clinical Focus, 2012, 27(7): 610-611.
[5]	. [J]. Clinical Focus, 2012, 27(1): 86-88.
[6]	. [J]. CLINICAL FOCUS, 2011, 26(9): 808-0.
[7]	HE Zhou-tao;XIE Xian-he;WEI Hong;LANG Cheng. Comparison of five methods for Helicobacter pylorus detection [J]. CLINICAL FOCUS, 2011, 26(7): 570-0.
[8]	LU Shui-rong;YANG Xiao-qing. Value of ultrathin transnasal gastroscopy in percutaneous endoscopic gastrostomy [J]. CLINICAL FOCUS, 2011, 26(4): 312-314.
[9]	. [J]. CLINICAL FOCUS, 2010, 25(23): 2078-2079.
[10]	. [J]. CLINICAL FOCUS, 2010, 25(11): 981-982.
[11]	. [J]. CLINICAL FOCUS, 2010, 25(1): 72-74.
[12]	. [J]. CLINICAL FOCUS, 2009, 24(16): 1429-1430.
[13]	. [J]. CLINICAL FOCUS, 2009, 24(15): 1368-1369.
[14]	. [J]. CLINICAL FOCUS, 2009, 24(2): 137-138.
[15]	. [J]. CLINICAL FOCUS, 2009, 24(2): 155-156.